English Chinese (Simplified) Danish German Greek Icelandic Italian Japanese Korean Russian Spanish Vietnamese
    You are here:
  • Home
  • Blog
  • Elimination of private medical patent ownership? Solution?

|

A solution for elimination private ownership of medical patent would result in cheaper medical drugs and innovation in medical field. Feel free to leave your comments and your solutions at bottom of article.

We would like to share a solution proposed by Aidan Hollis .

Abstract:

Because pharmaceutical markets are dysfunctional, the patent system does not effectively stimulate drug research and development. Instead, it induces large amounts of research into drugs with little incremental therapeutic value, while providing inadequate incentives to innovate in really novel areas. At the same time, patents result in high prices which exclude many users from access to potentially life-saving therapies. In this paper, I propose a novel reward system for pharmaceutical innovation, in which innovators are rewarded based on the incremental therapeutic benefits of their innovation. This would
align innovators’ incentives with social objectives, and lead to the best possible allocation of research investment. With rewards paid directly to innovators, patents could be compulsory licensed to enable competitive pricing, thus solving problems of drug access. Government expenditures on rewards could be largely funded through reduced expenditures on patented drugs, and pharmaceutical innovators could continue to earn a healthy return on their investments.

source:An Efficient Reward System for Pharmaceutical Innovation, Aidan Hollis, Department of Economics, university of Calgary, Institute of Health Economics Draft - Most recent version at http://econ.ucalgary.ca/hollis.htm      url ink

Each year type 1 diabetes  costs 14.4 billions of dollars  in mdecal costs and lost income. source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901386/

Addthis

Add comment


Security code
Refresh

Join hdiabetes.com lobby group newsletter now.
Use the newsletter sign-up form at top left.